Colón-López, Vivian
Alvelo-Fernández, Paola M.
Centeno-Alvarado, Nadia
Agudelo Salas, Ivony Y.
Rolón Colón, Yadira
Pabón Martínez, María
Rodríguez-Lebrón, Jorge L.
Reyes-Pulliza, Juan C.
Funding for this research was provided by:
Centers for Disease Control and Prevention (5NU62PS055075-03-00, 5NU62PS055075-03-00, 5NU62PS055075-03-00, 5NU62PS055075-03-00, 5NU62PS055075-03-00, 5NU62PS055075-03-00, 5NU62PS055075-03-00)
Article History
Received: 28 June 2022
Accepted: 28 February 2023
First Online: 18 April 2023
Declarations
:
: Ethics approval for this study was obtained through the UPR-Medical Science Campus Institutional Review Board (A0910118). All methods were performed in accordance with the guidelines, regulations, and local policies for human subjects protection. All participants agreed to participate in the study through written informed consent, which the interviewer read before beginning the survey. Respondents had the option of participating in the survey but decline the HIV or HCV tests that were offered.
: Not applicable.
: The authors declare that they have no competing interests.